层粘连蛋白γ2(LAMC2)重组蛋白
Recombinant Laminin Gamma 2 (LAMC2)
B2T; EBR2; EBR2A; LAMB2T; LAMNB2; Kalinin/nicein/epiligrin 100 kDa subunit; Cell-scattering factor 140 kDa subunit; Ladsin 140 kDa; Large adhesive scatter factor 140 kDa
- 编号RPC083Mu01
- 物种Mus musculus (Mouse，小鼠)相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位分泌, 细胞外基质
- 预测分子量54.2kDa
- 实际分子量54kDa(差异分析请参阅说明书)
- 片段与标签Met973~Gln1193 with N-terminal His and GST Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 80%
- 等电点5.4
- 应用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载英文说明书 中文说明书
- 规格10µg50µg200µg1mg5mg
- 价格¥ 1046¥ 2616¥ 5232¥ 15696¥ 39240
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
产品包装(模拟)
产品包装(模拟)
Figure . Gene Sequencing (extract)
Figure. SDS-PAGE
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Mus musculus (Mouse，小鼠) | 应用(仅供研究使用，不用于临床诊断！) |
| RPC083Mu01 | 层粘连蛋白γ2(LAMC2)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC083Mu01 | 层粘连蛋白γ2(LAMC2)多克隆抗体 | WB |
| LAC083Mu81 | 层粘连蛋白γ2(LAMC2)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. |
| LAC083Mu71 | 层粘连蛋白γ2(LAMC2)多克隆抗体(生物素标记) | WB; IHC; ICC. |
参考文献
| 杂志 | 参考文献 |
| Molecular & Cellular Proteomics | LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues[Mcponline: 023507] |
| Clinical Cancer Research | Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer[Pubmed:25239611] |
| British journal of cancer | Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer[PubMed: 26180921] |
| U.S. National Library of Medicine | Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer[pubmed:27462170] |
| American Journal of Obstetrics & Gynecology MFM | PRETERM BIRTH PREDICTION IN ASYMPTOMATIC WOMEN AT MID-GESTATION USING A PANEL OF NOVEL PROTEIN BIOMARKERS: The Prediction of PreTerm …[] |
| Biomarkers of Preterm Birth[] |